Twenty-Four Month Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People With HIV: Real-World Data From the BICSTaR Japan Cohort

Journal of Infection and Chemotherapy · Published 2026-08-01 · DOI 10.1016/j.jiac.2026.103047

Free full text

Authors (11)

Dai Watanabe, Katsuji Teruya, Yoshiyuki Yokomaku, Rumi Minami, Tomoyuki Endo, Nao Taguchi, Johanna Ramroth, Andrea Marongiu, David Thorpe, Takuma Shirasaka, Shinichi Oka

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Watanabe, D., Teruya, K., Yokomaku, Y., et al. (2026). Twenty-Four Month Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People With HIV: Real-World Data From the BICSTaR Japan Cohort. Journal of Infection and Chemotherapy. https://doi.org/10.1016/j.jiac.2026.103047

Related articles